Asymmetric dimethylarginine is not involved in ovariectomy-induced ostoepenia in rats

Comparative Medicine

Volumn 55, Issue 1, 2005, Pages 30-33

  Peng, Wei Jie ^a   Jiang, Jun Ling ^a   Jia, Su Jie ^a   Li, Dai ^a   Zhang, Xiao Jie ^a   Luo, Dan ^a   Liao, Er Yuan ^a   Deng, Han Wu ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESTRADIOL; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRITE; DIMETHYLARGININE; DRUG DERIVATIVE; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; FEMUR; LUMBAR SPINE; NONHUMAN; OSTEOPENIA; OVARIECTOMY; RAT; TIBIA; ANIMAL; BLOOD; BONE; METABOLIC BONE DISEASE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ARGININE; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; ESTROGENS; FEMALE; NITRATES; NITRITES; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 24644477460     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Armour, K. E., K. J. Armour, M. E. Gallagher, A. Godecke, M. H. Helfrich, D. M. Reid, and S. H. Ralston. 2001. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 142:760-766.
2. Blum, A., L. Hathaway, R. Mincemoyer, W. H. Schenke, M. Kirby, G. Csako, M. A. Waclawiw, J. A. Panza, and R. O. Cannon III. 2000. Oral L-arginine in patients with coronary artery disease on medical management. Circulation 101:2160-2164.
3. Blum, A., L. Hathaway, R. Mincemoyer, W. H. Schenke, M. Kirby, G. Csako, M. A. Waclawiw, J. A. Panza, and R. O. Cannon III. 2000. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy post-menopausal women. J. Am. Coll. Cardiol. 35:271-276.
4. Bode-Boger, S. M., R. H. Boger, S. Kienke, W. Junker, and J. C. Frolich. 1996. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem. Biophys. Res. Commun. 219:598-603.
5. Bode-Boger, S. M., J. Muke, A. Surdacki, G. Brabant, R. H. Boger, and J. C. Frolich. 2003. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc. Med. 8:77-81.
6. Cicinelli, E., L. J. Ignarro, M. G. Matteo, P. Galantino, L. M. Schonauer, and N. Falco. 1999. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women. Am. J. Obstet. Gynecol. 180:334-339.
7. Cooke, J. P. 2000. Does ADMA cause endothelial dysfunction? Arterioscler. Thromb. Vasc. Biol. 20:2032-2037.
8. Gomez-Zubeldia, M. A., R. Hernandez, J. Viguera, J. J. Arbues, A. Aparicio, and J. C. Millan. 2000. Effect of bilateral ovariectomy and ovarian steroid hormones on the antioxidant systems and plasma malondialdehyde levels in Wistar rats. Endocr. Res. 26:97-107.
9. Holden, D. P., J. E. Cartwright, S. S. Nussey, and G. S. Whitley. 2003. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108:1575-1580.
10. Hukkanen, M., L. A. Platts, T. Lawes, S. I. Girgis, Y. T. Konttinen, A. E. Goodship, I. Macintyre, and J. M. Polak. 2003. Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone 32:142-149.
11. Ito, A., P. S. Tsao, S. Adimoolam, M. Kimoto, T. Ogawa, and J. P. Cooke. 1999. Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99:3092-3095.
12. Lam, K. K., S. T. Ho, and M. H. Yen. 2002. Tetrahydrobiopterin improves vascular endothelial function in ovariectomized rats. J. Biomed. Sci. 9:119-125.
13. Leiper, J. and P. Vallance. 1999. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res. 43:542-548.
14. Loscalzo, J. 2000. What we know and don't know about L-arginine and NO. Circulation 101:2126-2129.
15. Lu, R., C. P. Hu, X. P. Wu, E. Y. Liao, and Y. J. Li. 2002. Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats. Comp. Med. 52:224-228.
16. Mutlu-Turkoglu, U., E. Ilhan, S. Oztezcan, A. Kuru, G. Aykac-Toker, and M. Uysal. 2003. Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin. Biochem. 36:397-400.
17. Nathan,L. and G. Chaudhuri. 1998. Antioxidant and prooxidant actions of estrogens: potential physiological and clinical implications. Semin. Reprod. Endocrinol. 16:309-314.
18. Post, M. S., M. O. Verhoeven, M. J. Mooren Van Der, P. Kenemans, C. D. Stehouwer, and T. Teerlink. 2003. Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women. J. Clin. Endocrinol. Metab. 88:4221-4226.
19. Rosen, C. J. and C. R. Kessenich. 1997. The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy. Endocrinol. Metab. Clin. North. Am. 26:295-311.
20. Rosselli, M., B. Imthurn, P. J. Keller, E. K. Jackson, and R. K. Dubey. 1995. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension 25:848-853.
21. Sagraves, R. 1995. Estrogen therapy for postmenopausal symptoms and prevention of osteoporosis. J. Clin. Pharmacol. 35(9 Suppl.):2S-10S.
22. Sydow, K. and T. Munzel. 2003. ADMA and oxidative stress. Atheroscler. Suppl. 4:41-51.
23. Sydow, K., E. Schwedhelm, N. Arakawa, S. M. Bode-Boger, D. Tsikas, B. Hornig, J. C. Frolich, and R. H. Boger. 2003. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovasc. Res. 57:244-252.
24. Teerlink, T., S. J. Neele, S. de Jong, J. C. Netelenbos, and C. D. Stehouwer. 2003. Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin. Sci. (London). 105:67-71.
25. Van't Hof, R. J., and S. H. Ralston. 2001. Nitric oxide and bone. Immunology 103:255-261.
26. Wimalawansa, S. J. 2000. Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J. Bone Miner. Res. 15:2240-2244.
27. Wimalawansa, S. J., G. DeMarco, P. Gangula, C. Yallampalli. 1996. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 18:301-304.
28. Xiao, Z. S., L. D. Quarles, Q. Q. Chen, Y. H. Yu, X. P. Qu, C. H. Jiang, H. W. Deng, Y. J. Li, and H. H. Zhou. 2001. Effect of asymmetric dimethylarginine on osteoblastic differentiation. Kidney Int. 60:1699-1704.
29. Yen, S. H. and J. T. Pan. 1999. Nitric oxide plays an important role in the diurnal change of tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in ovariectomized, estrogen/progesterone-treated rats. Endocrinology 140:286-291.